Δημοσιεύσεις

Δημοσιεύσεις

TitleAuthorsCitationJournal/BookPublication YearLink
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial MyofibroblastsKokkotis G, Filidou E, Tarapatzi G, Spathakis M, Kandilogiannakis L, Dovrolis N, Arvanitidis K, Drygiannakis I, Valatas V, Vradelis S, Manolopoulos VG, Paspaliaris V, Kolios G, Bamias G.Inflamm Bowel Dis. 2024 Nov 4;30(11):2162-2173. doi: 10.1093/ibd/izae098.Inflamm Bowel Dis2024Link
Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative ColitisDrygiannakis I, Valatas V, Filidou E, Tzenaki N, Archontoulaki E, Dovrolis N, Kandilogiannakis L, Kefalogiannis G, Sidiropoulos P, Kolios G, Koutroubakis IE.Dig Dis Sci. 2024 Oct;69(10):3773-3785. doi: 10.1007/s10620-024-08640-1. Epub 2024 Sep 25.Dig Dis Sci2024Link
Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel DiseaseDrygiannakis I, Kolios G, Filidou E, Bamias G, Valatas V.Inflamm Bowel Dis. 2024 Sep 3;30(9):1604-1618. doi: 10.1093/ibd/izae066.Inflamm Bowel Dis2024Link
Landscape of Interactions between Stromal and Myeloid Cells in Ileal Crohn's Disease; Indications of an Important Role for Fibroblast-Derived CCL-2Dovrolis N, Valatas V, Drygiannakis I, Filidou E, Spathakis M, Kandilogiannakis L, Tarapatzi G, Arvanitidis K, Bamias G, Vradelis S, Manolopoulos VG, Paspaliaris V, Kolios G.Biomedicines. 2024 Jul 26;12(8):1674. doi: 10.3390/biomedicines12081674.Biomedicines2024Link
Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and FibrosisSpathakis M, Dovrolis N, Filidou E, Kandilogiannakis L, Tarapatzi G, Valatas V, Drygiannakis I, Paspaliaris V, Arvanitidis K, Manolopoulos VG, Kolios G, Vradelis S.Pharmaceuticals (Basel). 2024 Apr 12;17(4):492. doi: 10.3390/ph17040492.Pharmaceuticals (Basel)2024Link
Editorial: Stromal and immune cell interactions in intestinal inflammation and fibrosisValatas V, Kitamura K, Ward SG, Kolios G.Front Immunol. 2023 Feb 16;14:1152140. doi: 10.3389/fimmu.2023.1152140. eCollection 2023.Front Immunol2023Link
Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?Dovrolis N, Filidou E, Tarapatzi G, Kokkotis G, Spathakis M, Kandilogiannakis L, Drygiannakis I, Valatas V, Arvanitidis K, Karakasiliotis I, Vradelis S, Manolopoulos VG, Paspaliaris V, Bamias G, Kolios G.Front Immunol. 2022 Dec 23;13:1058237. doi: 10.3389/fimmu.2022.1058237. eCollection 2022.Front Immunol2022Link
The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and Chemokine Responses in Human Intestinal Subepithelial MyofibroblastsTarapatzi G, Filidou E, Kandilogiannakis L, Spathakis M, Gaitanidou M, Arvanitidis K, Drygiannakis I, Valatas V, Kotzampassi K, Manolopoulos VG, Kolios G, Vradelis S.Pharmaceuticals (Basel). 2022 Oct 20;15(10):1293. doi: 10.3390/ph15101293.Pharmaceuticals (Basel)2022Link
Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and FibrosisKandilogiannakis L, Filidou E, Drygiannakis I, Tarapatzi G, Didaskalou S, Koffa M, Arvanitidis K, Bamias G, Valatas V, Paspaliaris V, Kolios G.Stem Cells Int. 2021 Jul 27;2021:9929461. doi: 10.1155/2021/9929461. eCollection 2021.Stem Cells Int2021Link
Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics AnalysisAyiomamitis GD, Notas G, Vasilakaki T, Tsavari A, Vederaki S, Theodosopoulos T, Kouroumalis E, Zaravinos A.Cancers (Basel). 2019 Oct 11;11(10):1536. doi: 10.3390/cancers11101536.Cancers (Basel)2019Link
TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal ImmunityValatas V, Kolios G, Bamias G.Front Immunol. 2019 Mar 27;10:583. doi: 10.3389/fimmu.2019.00583. eCollection 2019.Front Immunol2019Link
Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico ApproachDovrolis N, Drygiannakis I, Filidou E, Kandilogiannakis L, Arvanitidis K, Tentes I, Kolios G, Valatas V.Inflamm Bowel Dis. 2019 Jan 10;25(2):217-225. doi: 10.1093/ibd/izy328.Inflamm Bowel Dis2019Link
The Length of Surgical Skin Incision in Postoperative Inflammatory ReactionIoannidis A, Arvanitidis K, Filidou E, Valatas V, Stavrou G, Michalopoulos A, Kolios G, Kotzampassi K.JSLS. 2018 Oct-Dec;22(4):e2018.00045. doi: 10.4293/JSLS.2018.00045.JSLS2018Link
Cytokine Receptor Profiling in Human Colonic Subepithelial Myofibroblasts: A Differential Effect of Th Polarization-Associated Cytokines in Intestinal FibrosisFilidou E, Valatas V, Drygiannakis I, Arvanitidis K, Vradelis S, Kouklakis G, Kolios G, Bamias G.Inflamm Bowel Dis. 2018 Sep 15;24(10):2224-2241. doi: 10.1093/ibd/izy204.Inflamm Bowel Dis2018Link
Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological CorrelationsEmmanouil G, Ayiomamitis G, Zizi-Sermpetzoglou A, Tzardi M, Moursellas A, Voumvouraki A, Kouroumalis E.Anal Cell Pathol (Amst). 2018 Apr 16;2018:1616973. doi: 10.1155/2018/1616973. eCollection 2018.Anal Cell Pathol (Amst)2018Link
Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cellsKiagiadaki F, Kampa M, Voumvouraki A, Castanas E, Kouroumalis E, Notas G.Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):891-899. doi: 10.1016/j.bbadis.2017.12.031. Epub 2017 Dec 26.Biochim Biophys Acta Mol Basis Dis2018Link
Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, GreeceCoucoutsi C, Emmanouil G, Goulielmos G, Sfakianaki O, Koutroubakis IE, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1284-1289. doi: 10.1097/MEG.0000000000000947.Eur J Gastroenterol Hepatol2017Link
Stromal and immune cells in gut fibrosis: the myofibroblast and the scarfaceValatas V, Filidou E, Drygiannakis I, Kolios G.Ann Gastroenterol. 2017;30(4):393-404. doi: 10.20524/aog.2017.0146. Epub 2017 Apr 12.Ann Gastroenterol2017Link
Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesisGkouskou KK, Ioannou M, Pavlopoulos GA, Georgila K, Siganou A, Nikolaidis G, Kanellis DC, Moore S, Papadakis KA, Kardassis D, Iliopoulos I, McDyer FA, Drakos E, Eliopoulos AG.Oncogene. 2016 May 12;35(19):2496-505. doi: 10.1038/onc.2015.307. Epub 2015 Aug 17.Oncogene2016Link
Primary biliary cirrhosis: From bench to bedsideKouroumalis E, Notas G.World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):32-58. doi: 10.4292/wjgpt.v6.i3.32.World J Gastrointest Pharmacol Ther2015Link
Intraperitoneal application of phospholipids for the prevention of postoperative adhesions: a possible role of myofibroblastsFotiadis K, Filidou E, Arvanitidis K, Valatas V, Stavrou G, Basdanis G, Paspaliaris V, Kolios G, Kotzampassi K.J Surg Res. 2015 Aug;197(2):291-300. doi: 10.1016/j.jss.2015.04.036. Epub 2015 Apr 16.J Surg Res2015Link
Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issuesValatas V, Bamias G, Kolios G.Eur J Pharmacol. 2015 Jul 15;759:253-64. doi: 10.1016/j.ejphar.2015.03.017. Epub 2015 Mar 23.Eur J Pharmacol2015Link
Telomerase: a target for colorectal cancer treatment?Kouroumalis E.Cell Cycle. 2015;14(22):3513-4. doi: 10.1080/15384101.2015.1032638.Cell Cycle2015Link
Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activityAyiomamitis GD, Notas G, Zaravinos A, Drygiannakis I, Georgiadou M, Sfakianaki O, Mastrodimou N, Thermos K, Kouroumalis E.Oncoscience. 2014 Jun 30;1(6):457-67. doi: 10.18632/oncoscience.58. eCollection 2014.Oncoscience2014Link
Differences in telomerase activity between colon and rectal cancerAyiomamitis GD, Notas G, Zaravinos A, Zizi-Sermpetzoglou A, Georgiadou M, Sfakianaki O, Kouroumallis E.Can J Surg. 2014 Jun;57(3):199-208. doi: 10.1503/cjs.031312.Can J Surg2014Link
Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cellsKlironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E.Regul Pept. 2014 Jan 10;188:5-12. doi: 10.1016/j.regpep.2013.11.002. Epub 2013 Nov 26.Regul Pept2014Link
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseasesValatas V, Vakas M, Kolios G.Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(11):G763-85. doi: 10.1152/ajpgi.00004.2013. Epub 2013 Aug 29.Am J Physiol Gastrointest Liver Physiol2013Link
Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosisSfakianaki O, Tzardi M, Voumvouraki A, Afgoustaki A, Koulentaki M, Kouroumalis E.World J Hepatol. 2013 Oct 27;5(10):568-76. doi: 10.4254/wjh.v5.i10.568.World J Hepatol2013Link
Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosisDrygiannakis I, Valatas V, Sfakianaki O, Bourikas L, Manousou P, Kambas K, Ritis K, Kolios G, Kouroumalis E.J Crohns Colitis. 2013 May;7(4):286-300. doi: 10.1016/j.crohns.2012.04.008. Epub 2012 May 9.J Crohns Colitis2013Link
CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acidManousou P, Kolios G, Drygiannakis I, Koulentaki M, Pyrovolaki K, Voumvouraki A, Notas G, Bourikas L, Papadaki HA, Kouroumalis E.Clin Exp Immunol. 2013 Apr;172(1):9-15. doi: 10.1111/cei.12032.Clin Exp Immunol2013Link
Genetic variants associated with susceptibility to mother-to-child transmission of hepatitis B virusChatzidaki V, Choumerianou D, Dimitriou H, Kouroumalis E, Galanakis E.Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1185-90. doi: 10.1097/MEG.0b013e328356440f.Eur J Gastroenterol Hepatol2012Link
Polymorphisms of genes related to endothelial cells are associated with primary biliary cirrhosis patients of Cretan originMantaka A, Goulielmos GN, Koulentaki M, Tsagournis O, Voumvouraki A, Kouroumalis EA.Hum Immunol. 2012 Aug;73(8):829-35. doi: 10.1016/j.humimm.2012.05.003. Epub 2012 May 18.Hum Immunol2012Link
Increased serum activin-A differentiates alcoholic from cirrhosis of other aetiologiesVoumvouraki A, Notas G, Koulentaki M, Georgiadou M, Klironomos S, Kouroumalis E.Eur J Clin Invest. 2012 Aug;42(8):815-22. doi: 10.1111/j.1365-2362.2012.02647.x. Epub 2012 Feb 4.Eur J Clin Invest2012Link
TNF receptors in Kupffer cellsGeorgiadou M, Notas G, Xidakis C, Drygiannakis I, Sfakianaki O, Klironomos S, Valatas V, Kouroumalis E.J Recept Signal Transduct Res. 2011 Aug;31(4):291-8. doi: 10.3109/10799893.2011.586354. Epub 2011 Jun 21.J Recept Signal Transduct Res2011Link
Serum surrogate markers of liver fibrosis in primary biliary cirrhosisVoumvouraki A, Koulentaki M, Notas G, Sfakianaki O, Kouroumalis E.Eur J Intern Med. 2011 Feb;22(1):77-83. doi: 10.1016/j.ejim.2010.10.002. Epub 2010 Nov 13.Eur J Intern Med2011Link
Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cellsTsagarakis NJ, Drygiannakis I, Batistakis AG, Kolios G, Kouroumalis EA.World J Gastroenterol. 2011 Jan 21;17(3):313-21. doi: 10.3748/wjg.v17.i3.313.World J Gastroenterol2011Link
Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studiesManousou P, Kolios G, Valatas V, Drygiannakis I, Bourikas L, Pyrovolaki K, Koutroubakis I, Papadaki HA, Kouroumalis E.Clin Exp Immunol. 2010 Nov;162(2):337-47. doi: 10.1111/j.1365-2249.2010.04248.x.Clin Exp Immunol2010Link
Increased ΤGF-β3 in primary biliary cirrhosis: an abnormality related to pathogenesis?Voumvouraki A, Koulentaki M, Tzardi M, Sfakianaki O, Manousou P, Notas G, Kouroumalis E.World J Gastroenterol. 2010 Oct 28;16(40):5057-64. doi: 10.3748/wjg.v16.i40.5057.World J Gastroenterol2010Link
Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patientsSfakianaki O, Koulentaki M, Tzardi M, Tsangaridou E, Theodoropoulos PA, Castanas E, Kouroumalis EA.World J Gastroenterol. 2010 Oct 21;16(39):4938-43. doi: 10.3748/wjg.v16.i39.4938.World J Gastroenterol2010Link
A concentration-dependent effect of ursodeoxycholate on apoptosis and caspases activities of HepG2 hepatocellular carcinoma cellsTsagarakis NJ, Drygiannakis I, Batistakis AG, Kolios G, Kouroumalis EA.Eur J Pharmacol. 2010 Aug 25;640(1-3):1-7. doi: 10.1016/j.ejphar.2010.04.023. Epub 2010 May 6.Eur J Pharmacol2010Link
Serum TGF-beta2 and TGF-beta3 are increased and positively correlated to pain, functionality, and radiographic staging in osteoarthritisKapetanakis S, Drygiannakis I, Kazakos K, Papanas N, Kolios G, Kouroumalis E, Verettas DA.Orthopedics. 2010 Aug 11;33(8). doi: 10.3928/01477447-20100625-09.Orthopedics2010Link
Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methodsTsangaridou E, Polioudaki H, Sfakianaki R, Samiotaki M, Tzardi M, Koulentaki M, Panayotou G, Kouroumalis E, Castanas E, Theodoropoulos PA.BMC Gastroenterol. 2010 Mar 8;10:28. doi: 10.1186/1471-230X-10-28.BMC Gastroenterol2010Link
Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracilBourikas LA, Kolios G, Valatas V, Notas G, Drygiannakis I, Pelagiadis I, Manousou P, Klironomos S, Mouzas IA, Kouroumalis E.Br J Pharmacol. 2009 Jun;157(3):362-70. doi: 10.1111/j.1476-5381.2009.00161.x. Epub 2009 Apr 9.Br J Pharmacol2009Link
Oxidative stress due to anesthesia and surgical trauma: importance of early enteral nutritionKotzampassi K, Kolios G, Manousou P, Kazamias P, Paramythiotis D, Papavramidis TS, Heliadis S, Kouroumalis E, Eleftheriadis E.Mol Nutr Food Res. 2009 Jun;53(6):770-9. doi: 10.1002/mnfr.200800166.Mol Nutr Food Res2009Link
Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interactionManousou P, Kolios G, Drygiannakis I, Pyrovolaki K, Bourikas L, Papadaki HA, Kouroumalis E.J Gastroenterol Hepatol. 2008 Dec;23(12):1823-33. doi: 10.1111/j.1440-1746.2008.05486.x. Epub 2008 Aug 28.J Gastroenterol Hepatol2008Link
Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cellsKolios G, Valatas V, Manousou P, Xidakis C, Notas G, Kouroumalis E.Mol Cell Biochem. 2008 Dec;319(1-2):91-8. doi: 10.1007/s11010-008-9881-7. Epub 2008 Jul 16.Mol Cell Biochem2008Link
Resistin: another rising biomarker in inflammatory bowel disease?Karmiris K, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1035-7. doi: 10.1097/MEG.0b013e3282f16449.Eur J Gastroenterol Hepatol2007Link
RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cellsXidakis C, Mastrodimou N, Notas G, Renieri E, Kolios G, Kouroumalis E, Thermos K.Regul Pept. 2007 Oct 4;143(1-3):76-82. doi: 10.1016/j.regpep.2007.03.005. Epub 2007 Mar 30.Regul Pept2007Link
The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel diseaseKarmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2007 Sep;19(9):789-94. doi: 10.1097/MEG.0b013e3282202bca.Eur J Gastroenterol Hepatol2007Link
Enteral nutrition affects nitric oxide production in peripheral blood and liver after a postoperative lipopolysaccharide-induced endotoxemia in ratsKolios G, Kotzampassi K, Manousou P, Paramythiotis D, Papanastasiou H, Drygiannakis I, Notas G, Tsagarakis N, Eleftheriadis E, Kouroumalis E.Nutrition. 2007 Jul-Aug;23(7-8):575-81. doi: 10.1016/j.nut.2007.04.010. Epub 2007 Jun 7.Nutrition2007Link
Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestationsKoutroubakis IE, Karmiris K, Bourikas L, Kouroumalis EA, Drygiannakis I, Drygiannakis D.Inflamm Bowel Dis. 2007 Apr;13(4):504-5. doi: 10.1002/ibd.20038.Inflamm Bowel Dis2007Link
The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptorsNotas G, Kampa M, Nifli AP, Xidakis K, Papasava D, Thermos K, Kouroumalis E, Castanas E.Eur J Pharmacol. 2007 Jan 19;555(1):1-7. doi: 10.1016/j.ejphar.2006.10.018. Epub 2006 Oct 18.Eur J Pharmacol2007Link
Role of Kupffer cells in the pathogenesis of liver diseaseKolios G, Valatas V, Kouroumalis E.World J Gastroenterol. 2006 Dec 14;12(46):7413-20. doi: 10.3748/wjg.v12.i46.7413.World J Gastroenterol2006Link
Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activationNotas G, Nifli AP, Kampa M, Vercauteren J, Kouroumalis E, Castanas E.Biochim Biophys Acta. 2006 Nov;1760(11):1657-66. doi: 10.1016/j.bbagen.2006.09.010. Epub 2006 Sep 22.Biochim Biophys Acta2006Link
Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epitheliumKolios G, Manousou P, Bourikas L, Notas G, Tsagarakis N, Mouzas I, Kouroumalis E.Eur J Clin Invest. 2006 Oct;36(10):720-9. doi: 10.1111/j.1365-2362.2006.01710.x.Eur J Clin Invest2006Link
Pathogenesis of primary biliary cirrhosis: a unifying modelKouroumalis E, Notas G.World J Gastroenterol. 2006 Apr 21;12(15):2320-7. doi: 10.3748/wjg.v12.i15.2320.World J Gastroenterol2006Link
Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel diseaseKoutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA.Eur J Clin Invest. 2006 Feb;36(2):127-32. doi: 10.1111/j.1365-2362.2006.01602.x.Eur J Clin Invest2006Link
Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel diseaseKarmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA.Inflamm Bowel Dis. 2006 Feb;12(2):100-5. doi: 10.1097/01.MIB.0000200345.38837.46.Inflamm Bowel Dis2006Link
Neuropeptide urocortin and its receptors are expressed in rat Kupffer cellsCharalampopoulos I, Androulidaki A, Minas V, Chatzaki E, Tsatsanis C, Notas G, Xidakis C, Kolios G, Kouroumalis E, Margioris AN, Gravanis A.Neuroendocrinology. 2006;84(1):49-57. doi: 10.1159/000096827. Epub 2006 Nov 3.Neuroendocrinology2006Link
kappa-opioids induce a reversible inhibition of CFU-GM from CD133(+) cord blood cellsDimitriou H, Bakogeorgou E, Kampa M, Notas G, Stiakaki E, Kouroumalis E, Kalmanti M, Castanas E.Cytotherapy. 2006;8(4):367-74. doi: 10.1080/14653240600847183.Cytotherapy2006Link
Immunomodulatory cytokines suppress epithelial nitric oxide production in inflammatory bowel disease by acting on mononuclear cellsLinehan JD, Kolios G, Valatas V, Robertson DA, Westwick J.Free Radic Biol Med. 2005 Dec 15;39(12):1560-9. doi: 10.1016/j.freeradbiomed.2005.07.019. Epub 2005 Aug 19.Free Radic Biol Med2005Link
Pancreatic autoantibodies in Greek patients with inflammatory bowel diseaseKoutroubakis IE, Drygiannakis D, Karmiris K, Drygiannakis I, Makreas S, Kouroumalis EA.Dig Dis Sci. 2005 Dec;50(12):2330-4. doi: 10.1007/s10620-005-3056-0.Dig Dis Sci2005Link
The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel diseaseKarmiris K, Koutroubakis IE, Kouroumalis EA.Inflamm Bowel Dis. 2005 Sep;11(9):847-55. doi: 10.1097/01.mib.0000178915.54264.8f.Inflamm Bowel Dis2005Link
Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assayNotas G, Miliaraki N, Kampa M, Dimoulios F, Matrella E, Hatzidakis A, Castanas E, Kouroumalis E.World J Gastroenterol. 2005 Jul 21;11(27):4194-8. doi: 10.3748/wjg.v11.i27.4194.World J Gastroenterol2005Link
Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotideXidakis C, Ljumovic D, Manousou P, Notas G, Valatas V, Kolios G, Kouroumalis E.Dig Dis Sci. 2005 May;50(5):935-41. doi: 10.1007/s10620-005-2668-8.Dig Dis Sci2005Link
Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosisDimoulios P, Kolios G, Notas G, Matrella E, Xidakis C, Koulentaki M, Tsagarakis N, Kouroumalis A, Kouroumalis E.Aliment Pharmacol Ther. 2005 Feb 1;21(3):227-34. doi: 10.1111/j.1365-2036.2005.02307.x.Aliment Pharmacol Ther2005Link
Effect of corticosteroids on nitric oxide production in inflammatory bowel disease: are leukocytes the site of action?Linehan JD, Kolios G, Valatas V, Robertson DA, Westwick J.Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G261-7. doi: 10.1152/ajpgi.00336.2004. Epub 2004 Sep 16.Am J Physiol Gastrointest Liver Physiol2005Link
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzleKolios G, Valatas V, Ward SG.Immunology. 2004 Dec;113(4):427-37. doi: 10.1111/j.1365-2567.2004.01984.x.Immunology2004Link
Serum angiogenin in inflammatory bowel diseaseKoutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA.Dig Dis Sci. 2004 Nov-Dec;49(11-12):1758-62. doi: 10.1007/s10620-004-9565-4.Dig Dis Sci2004Link
Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel diseaseKoutroubakis IE, Theodoropoulou A, Xidakis C, Sfiridaki A, Notas G, Kolios G, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1147-52. doi: 10.1097/00042737-200411000-00011.Eur J Gastroenterol Hepatol2004Link
Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseasesLjumovic D, Diamantis I, Alegakis AK, Kouroumalis EA.Clin Chim Acta. 2004 Nov;349(1-2):203-11. doi: 10.1016/j.cccn.2004.06.028.Clin Chim Acta2004Link
Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotideValatas V, Kolios G, Manousou P, Xidakis C, Notas G, Ljumovic D, Kouroumalis EA.Regul Pept. 2004 Aug 15;120(1-3):215-25. doi: 10.1016/j.regpep.2004.03.009.Regul Pept2004Link
Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell culturesVasilaki A, Papadaki T, Notas G, Kolios G, Mastrodimou N, Hoyer D, Tsilimbaris M, Kouroumalis E, Pallikaris I, Thermos K.Invest Ophthalmol Vis Sci. 2004 May;45(5):1499-506. doi: 10.1167/iovs.03-0835.Invest Ophthalmol Vis Sci2004Link
Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptorsNotas G, Kolios G, Mastrodimou N, Kampa M, Vasilaki A, Xidakis C, Castanas E, Thermos K, Kouroumalis E.J Hepatol. 2004 May;40(5):792-8. doi: 10.1016/j.jhep.2004.01.016.J Hepatol2004Link
Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: a possible anti-tumour mechanismXidakis C, Kolios G, Valatas V, Notas G, Mouzas I, Kouroumalis E.Anticancer Res. 2004 Mar-Apr;24(2B):833-41.Anticancer Res2004Link
Binge drinking and nitric oxide metabolites in chronic liver diseaseOekonomaki E, Notas G, Mouzas IA, Valatas V, Skordilis P, Xidakis C, Kouroumalis EA.Alcohol Alcohol. 2004 Mar-Apr;39(2):106-9. doi: 10.1093/alcalc/agh030.Alcohol Alcohol2004Link
Nitric oxide and pro-inflammatory cytokines in acute hepatitis BKoulentaki M, Notas G, Petinaki E, Valatas V, Mouzas IA, Castanas E, Kouroumalis EA.Eur J Intern Med. 2004 Feb;15(1):35-38. doi: 10.1016/j.ejim.2003.11.004.Eur J Intern Med2004Link
Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cellsValatas V, Kolios G, Manousou P, Notas G, Xidakis C, Diamantis I, Kouroumalis E.Br J Pharmacol. 2004 Feb;141(3):477-87. doi: 10.1038/sj.bjp.0705633. Epub 2004 Jan 12.Br J Pharmacol2004Link
Isolation of rat Kupffer cells: a combined methodology for highly purified primary culturesValatas V, Xidakis C, Roumpaki H, Kolios G, Kouroumalis EA.Cell Biol Int. 2003;27(1):67-73. doi: 10.1016/s1065-6995(02)00249-4.Cell Biol Int2003Link
Matrix metalloproteinases and their inhibitors in acute viral hepatitisKoulentaki M, Valatas V, Xidakis K, Kouroumalis A, Petinaki E, Castanas E, Kouroumalis E.J Viral Hepat. 2002 May;9(3):189-93. doi: 10.1046/j.1365-2893.2002.00351.x.J Viral Hepat2002Link
Depletion of non specific esterase activity in the colonic mucosa of patients with ulcerative colitisKolios G, Valatas V, Psilopoulos D, Petraki K, Kouroumalis E.Eur J Clin Invest. 2002 Apr;32(4):265-73. doi: 10.1046/j.1365-2362.2002.00969.x.Eur J Clin Invest2002Link
Apoptosis and apoptosis related proteins in chronic viral liver diseasePapakyriakou P, Tzardi M, Valatas V, Kanavaros P, Karydi E, Notas G, Xidakis C, Kouroumalis E.Apoptosis. 2002 Apr;7(2):133-41. doi: 10.1023/a:1014472430976.Apoptosis2002Link
Unraveling the mechanisms of thrombosis in inflammatory bowel diseaseKoutroubakis IE.Am J Gastroenterol. 2001 May;96(5):1325-7. doi: 10.1111/j.1572-0241.2001.03846.x.Am J Gastroenterol2001Link
Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, GreeceDrygiannakis D, Lionis C, Drygiannakis I, Pappas G, Kouroumalis E.BMC Gastroenterol. 2001;1:4. doi: 10.1186/1471-230x-1-4. Epub 2001 Jun 11.BMC Gastroenterol2001Link
Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinomaNotas G, Xidakis C, Valatas V, Kouroumalis A, Kouroumalis E.J Viral Hepat. 2001 Jan;8(1):63-9. doi: 10.1046/j.1365-2893.2001.00269.x.J Viral Hepat2001Link